Join as an individual or organization
A contribution by Jeff Lee from the ISSUP INEP Plus facilitators training course.
A specialist treatment provider for substance use disorder may have the skill to be a comprehensive care provider for substance use disorder but...
Let us...
The UNODC and WHO report Treatment and care for people with drug use disorders in contact with the criminal justice system: Alternatives to conviction or punishment examines how health-centred, evidence-based responses can be integrated...
This multicentre randomised controlled study evaluated a 3-year intersectoral intervention designed to reduce alcohol, tobacco, and cannabis use among adolescents in a tri-border region of Brazil, Argentina, and Paraguay. The intervention...
The article explores how artificial intelligence (AI) is currently used — and could be used — in the field of addiction research and treatment. The authors note that AI (machine learning, data mining, predictive analytics) offers...
Artificial intelligence (AI) is transforming how we understand and manage substance use disorders (SUDs). The following curated readings highlight current developments, practical applications, and ethical considerations for AI in this field...
AGENDA
2025 FDA Perspective: Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices
FDA Perspective: Regulatory Considerations for Digital Mental Health Therapeutics
Topic 1: Large Language Models in...
Objectives: This study systematically reviewed research on the utilization of chatbot-related technologies for the prevention, assessment, and treatment of various substance uses, including alcohol, nicotine, and other drugs.
Methods: Foll...
Addictive substances are prevalent world-wide, and their use presents a substantial and persistent public health problem. A wide range of digital interventions to decrease use and negative consequences thereof have been explored, differing...
Psychotherapy remains a fundamental component of mental health treatment, yet it encounters significant barriers to accessibility and efficacy. The integration of digital therapies, encompassing e-Health, m-Health...